Hydrogenated amorphous carbon films have been prepared from CH<sub>4</sub>+H<sub>2</sub>+Ar mixtures by plasma enhanced chemical vapor deposition. Films with various physical properties resulti...Hydrogenated amorphous carbon films have been prepared from CH<sub>4</sub>+H<sub>2</sub>+Ar mixtures by plasma enhanced chemical vapor deposition. Films with various physical properties resulting from different deposition conditions were used for the study. The deposition parameters varied included H<sub>2</sub>展开更多
[Objective] The aim was to study the sequence of aroA gene （synthetic gene in metabolic pathway of aromatic amino acids） of a pathogenic bacterium （Flavobacterium johnsoniae） causing gill-rote disease.[Method] Gen...[Objective] The aim was to study the sequence of aroA gene （synthetic gene in metabolic pathway of aromatic amino acids） of a pathogenic bacterium （Flavobacterium johnsoniae） causing gill-rote disease.[Method] Genomic DNA of strain M165 of F.johnsoniae was used as a template,three specific nested primers of 5＇end and 3＇end and arbitrary primer were used to amplify the aroA gene of strain M165 through Thermal asymmetric interlaced PCR （TAIL-PCR）.And the obtained sequence was analyzed.[Result] The electrophoresis determination result showed that the size of amplified product was consist with the expected product; sequencing analysis suggested that the full-length of aroA gene was 1 230 bp,enconding 410 amino acids.The amino acid sequence of aroA protein showed the highest level of similarity to amino acids sequence of aroA protein of F.johnsoniae.[Conclusion] TAIL-PCR provided a simple and efficient new method for the cloning of the gene sequence.Obtaining of full-length of aroA gene provided a foundation for further investigation on the effects of nutrition correlation factors such as aroA on the virulence of and virulence of F.johnsoniae.展开更多
To examine serum levels of sICAM 1 from normal controls and patients with thyroid diseases (simple goitre, Graves’ disease or Hashimoto’s thyroiditis) with 125 Ⅰ sICAM 1 RIA established in our lab Methods ...To examine serum levels of sICAM 1 from normal controls and patients with thyroid diseases (simple goitre, Graves’ disease or Hashimoto’s thyroiditis) with 125 Ⅰ sICAM 1 RIA established in our lab Methods Using 125 Ⅰ sICAM 1 RIA, serum sICAM 1 levels of 400 healthy individuals as the normal group and 1020 patients with simple goitre (SG), Graves’ disease (GD) or Hashimoto’s thyroiditis (HT) were examined for a comporative chinical study Results The serum level of sICAM 1 ( ±s ) in the normal group was 168 43±36 23 μg/L There was no significant difference between the normal and SG groups ( P 】0 05), whereas the serum levels of sICAM 1 in autoimmune thyroid diseases (GD or HT) were higher than those in the normal or SG groups ( P 【0 05, respectively) After GD patients received one of three medical treatments, their serum sICAM 1 levels decreased ( P 【0 05) After GD patients were treated and their thyroid function decreased to normal, their serum sICAM 1 levels were lower than those in relapsed GD patients ( P 【0 05) Conclusions sICAM 1 RIA can be used to examine autoimmune thyroid diseases Serum levels of sICAM 1 can be used as a parameter in diagnosing autoimmune thyroid disease and in evaluating the effects of therapy, drug administration or relapse in GD展开更多
文摘Hydrogenated amorphous carbon films have been prepared from CH<sub>4</sub>+H<sub>2</sub>+Ar mixtures by plasma enhanced chemical vapor deposition. Films with various physical properties resulting from different deposition conditions were used for the study. The deposition parameters varied included H<sub>2</sub>
基金Supported by The Natural Science Foundation of Guangdong Province(06024033)National Special Fund for the Agricultural Commonweal Industry(200803013)Earmarked Fund for Modern Agroindustry Technology Research System(nycytx-49-14)~~
文摘[Objective] The aim was to study the sequence of aroA gene （synthetic gene in metabolic pathway of aromatic amino acids） of a pathogenic bacterium （Flavobacterium johnsoniae） causing gill-rote disease.[Method] Genomic DNA of strain M165 of F.johnsoniae was used as a template,three specific nested primers of 5＇end and 3＇end and arbitrary primer were used to amplify the aroA gene of strain M165 through Thermal asymmetric interlaced PCR （TAIL-PCR）.And the obtained sequence was analyzed.[Result] The electrophoresis determination result showed that the size of amplified product was consist with the expected product; sequencing analysis suggested that the full-length of aroA gene was 1 230 bp,enconding 410 amino acids.The amino acid sequence of aroA protein showed the highest level of similarity to amino acids sequence of aroA protein of F.johnsoniae.[Conclusion] TAIL-PCR provided a simple and efficient new method for the cloning of the gene sequence.Obtaining of full-length of aroA gene provided a foundation for further investigation on the effects of nutrition correlation factors such as aroA on the virulence of and virulence of F.johnsoniae.
文摘To examine serum levels of sICAM 1 from normal controls and patients with thyroid diseases (simple goitre, Graves’ disease or Hashimoto’s thyroiditis) with 125 Ⅰ sICAM 1 RIA established in our lab Methods Using 125 Ⅰ sICAM 1 RIA, serum sICAM 1 levels of 400 healthy individuals as the normal group and 1020 patients with simple goitre (SG), Graves’ disease (GD) or Hashimoto’s thyroiditis (HT) were examined for a comporative chinical study Results The serum level of sICAM 1 ( ±s ) in the normal group was 168 43±36 23 μg/L There was no significant difference between the normal and SG groups ( P 】0 05), whereas the serum levels of sICAM 1 in autoimmune thyroid diseases (GD or HT) were higher than those in the normal or SG groups ( P 【0 05, respectively) After GD patients received one of three medical treatments, their serum sICAM 1 levels decreased ( P 【0 05) After GD patients were treated and their thyroid function decreased to normal, their serum sICAM 1 levels were lower than those in relapsed GD patients ( P 【0 05) Conclusions sICAM 1 RIA can be used to examine autoimmune thyroid diseases Serum levels of sICAM 1 can be used as a parameter in diagnosing autoimmune thyroid disease and in evaluating the effects of therapy, drug administration or relapse in GD
